Journal Home
Search for

Volume 89, Issue 1, Pages 118-123 (January 2008)


View previous. 19 of 49 View next.

Day-3 embryo morphology predicts euploidy among older subjects

Sharon E. Moayeri, M.D., M.P.H.aCorresponding Author Informationemail address, Rene B. Allen, M.D.b, Wendy R. Brewster, M.D., Ph.D.c, Moon H. Kim, M.D.c, Manuel Porto, M.D.c, Lawrence B. Werlin, M.D.d

Received 30 October 2006; received in revised form 29 January 2007; accepted 29 January 2007. published online 24 April 2007.

Objective

To evaluate whether day-3 embryo morphology predicts euploidy.

Design

Retrospective.

Setting

Private IVF center.

Patient(s)

Subjects (n = 144) undergoing in vitro fertilization and preimplantation genetic diagnosis (PGD).

Intervention(s)

Translate day-3 embryo characteristics into a standardized score.

Main Outcome Measure(s)

Day-3 embryo morphology score and PGD fluorescence in situ hybridization results for chromosomes: 13, 15, 16, 17, 18, 21, 22, X, and Y.

Result(s)

Of 1,043 biopsied blastomeres, 67% (n = 696) were chromosomally abnormal. Women with advanced maternal age (AMA) were 1.3 times more likely to have chromosomal errors (95% CI 1.1–1.4) than younger subjects (<38 years old). Morphology predicted PGD results in the AMA group (n = 553), but not in younger women. Fragmentation predicted euploidy in both the younger and the AMA group, but cell number did not.

Conclusion(s)

Day-3 embryo morphology selects for euploidy among AMA subjects but not among younger women who may have other factors responsible for embryo dysmorphism. However, cellular fragmentation is a sensitive proxy for selecting chromosomally normal embryos in both age groups. It is unclear that PGD-aneuploidy screening is a better tool for selecting which embryos to transfer than the standard approach of using day-3 embryo features, particularly among older women, a group for whom this technology is targeted.

a Department of Obstetrics and Gynecology, Stanford University Medical Center, Stanford, California

b Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, California

c Department of Obstetrics and Gynecology, University of California Irvine Medical Center, Orange, California

d Coastal Fertility Medical Center, Irvine, California

Corresponding Author InformationReprint requests: Sharon E. Moayeri, Stanford University, PCOR, 117 Encina Commons, Room 210, Mail code: 6019, Stanford, California, 94305 (FAX: 650-723-1919).

PII: S0015-0282(07)00335-4

doi:10.1016/j.fertnstert.2007.01.169


View previous. 19 of 49 View next.